MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
RKT.L stock logo

RKT.L

Reckitt Benckiser Group plc

$4773
-2
 (-0.04%)
Exchange:  LSE
Market Cap:  30.645B
Shares Outstanding:  713.759M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Consumer Defensive
Industry:  Household & Personal Products
   
CEO:  Kristoffer Loe Licht
Full Time Employees:  37900
Address: 
Turner House
Slough
SL1 3UH
GB
Website:  https://www.reckitt.com
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue14,607,00014,169,00014,205,000
Gross Profit8,760,0008,595,0008,634,000
EBITDA3,189,0002,950,0004,217,000
Operating Income2,531,0002,425,0004,217,000
Net Income1,643,0001,426,0003,182,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets27,136,00025,298,00025,068,000
Total Liabilities18,667,00018,578,00017,287,000
Total Stockholders Equity8,448,0006,699,0007,746,000
Total Debt8,537,0008,658,0008,430,000
Cash and Cash Equivalents1,387,000760,0001,952,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow2,636,0002,682,0002,297,000
Capital Expenditure-449,000-465,000-536,000
Free Cash Flow2,187,0002,217,0001,761,000
Net Income1,643,0002,104,0003,198,000
Net Change in Cash224,000-501,0001,072,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)15,134,020.183Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)16,550,227.337Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)15,467,000Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)7,057,133.824Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)7,717,524.340Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)7,212,405.397Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,970,143.109Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)3,333,860.124Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)3,055,659.732Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)5,062,750.761Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)5,536,511.451Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)5,174,141.773Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)4.670Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)5.100Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)4.540Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)7Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)5Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
3.11
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
12.37
?Enterprise Value
 (TTM)
: 
39.757B  ?EV/FCF
 (TTM)
: 
27.72
?Dividend Yield
 (TTM)
: 
0.09  ?Payout Ratio
 (TTM)
: 
0.37
?ROE
 (TTM)
: 
0.38  ?ROIC
 (TTM)
: 
0.15
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
1.09
?P/B
 (TTM)
: 
4.32  ?Current Ratio
 (TTM)
: 
0.85

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
1,064.53Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate RKT Intrinsic Value

Common questions about RKT.L valuation

Is Reckitt Benckiser Group plc (RKT.L) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Reckitt Benckiser Group plc (RKT.L) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is RKT.L a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether RKT.L trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is RKT.L’s P/E ratio?

You can see RKT.L’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for RKT.L?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is RKT.L a good long-term investment?

Whether RKT.L fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

RKT.L

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.04
MARKETSnap

Trading Metrics:

Open: 4787   Previous Close: 4775
Day Low: 4754   Day High: 4823
Year Low: 4574   Year High: 6522.92
Price Avg 50: 5522.78   Price Avg 200: 5913.16
Volume: 3.579M   Average Volume: 2.122M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read